Use the Search Fields to Find Information
Page 117 of 373
Natural Products Derived from Cannabis sativa for Pain Management
Please use this link to access this publication. Abstract Cannabis sativa is one of the oldest medicinal plants in human history. Even ancient physicians from hundreds
December 7, 2025
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
The word dementia describes a class of heterogeneous diseases which etiopathogenetic mechanisms are not well understood. There are different types of dementia, among which, Alzheimer’s
September 19, 2019
Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor
Abstract Natural cannabinoids and their synthetic substitutes are the most widely used recreational drugs. Numerous clinical cases describe acute toxic symptoms and neurological consequences following
August 5, 2024
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
Abstract Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a clinical challenge. Nabiximols (Nabiximols is the U.S. Adopted Name
November 22, 2023
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
Abstract Importance: There are no medications approved for treating cannabis dependence or withdrawal. The cannabis extract nabiximols (Sativex), developed as a multiple sclerosis treatment, offers a
November 4, 2024
Nabilone for the treatment of pain in fibromyalgia
Abstract A randomized, double-blind, placebo-controlled trial was conducted to determine the benefit of nabilone in pain management and quality of life improvement in 40 patients
November 15, 2023
N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
Abstract Cannabis use disorder is particularly prevalent and impairing among young people, and evidence-based treatments are limited. Prior trials of N-acetylcysteine, added to contingency management
April 18, 2026
Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent?
Myrcene (β-myrcene) is an abundant monoterpene which occurs as a major constituent in many plant species, including hops and cannabis. It is a popular flavouring
September 1, 2022
Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles
Please use this link to access this publication. Abstract Cannabis is used to treat various medical conditions, and lines are commonly classified according to their
October 3, 2024
Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre- and Postnatal Development
The endocannabinoid system, including its receptors (CB1 and CB2), endogenous ligands (‘endocannabinoids’), synthesising and degrading enzymes, as well as transporter molecules, has been detected from
September 19, 2019
Page 117 of 373